Drug
Tesamorelin
Tesamorelin: highest development phase Phase 2, developed by Hudson Biotech. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Hudson Biotech
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tesamorelin NCT07481734 | Phase 2 | Metabolic Associated Steatotic Liver Disease |
Latest
No recent events.
Follow Tesamorelin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.